SCHEMBL7363609

SCHEMBL7363609

CC[CH]C(=O)OC(C)[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL131152 0.78
SCHEMBL11177532 0.76 HCAR2 (0.32)
SCHEMBL11207248 0.76
SCHEMBL9637767 0.74 TSHR (0.43)
Water SCHEMBL11033305 0.74 HCAR2 (0.31)
SCHEMBL11207271 0.74
SCHEMBL5209514 0.74 MAPT (0.33)
SCHEMBL4847369 0.72 HCAR2 (0.30)
SCHEMBL8895865 0.71 CHRNB2 (0.30)
SCHEMBL4854686 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111196821-B Compounds, preparation method thereof and application thereof as near-infrared two-region fluorescent probe for detecting methylglyoxal 中国科学院上海药物研究所 2022-11-29 CN disclosed
WO-1992019278-A1 USE OF MACROLIDE COMPOUNDS FOR EYE DISEASES KURUME UNIVERSITY (JP) 1992-11-12 WO disclosed
WO-1991019495-A1 USE OF A MACROLIDE COMPOUND SUCH AS FK 506 FOR MANUFACTURING A MEDICAMENT FOR TREATING IDIOPATHIC THROMBOCYTOPENIC PURPURA AND BASEDOW'S DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-26 WO disclosed